Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185354
Status:
COMPLETED
Last Update Posted:
2015-12-31
First Post:
2005-09-13
Brief Title:
FC Patch Comparator Study
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Multi-center Open Randomized Parallel Group Comparison of Cycle Control for Seven Cycles and Endometrial Safety in a Subgroup for Thirteen Cycles of Contraceptive Patch SH P00331F 09 mg Ethinylestradiol19 mg Gestodene vs a Contraceptive Comparator Patch 06 mg Ethinylestradiol6 mg Norelgestromin in 400 Healthy Female Volunteers
Status:
COMPLETED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare bleeding pattern and safety of contraceptive patch SH P00331F to a marketed comparator
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG GermanyBayer Schering Pharma AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 307969 | OTHER | Study Number | None |
| 2004-000821-31 | EUDRACT_NUMBER | None | None |